Delivery Order SPE2DB22D2206-SPE2DB25FJN71
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.17 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic used in military and federal healthcare settings. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and the product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,224.08 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 13, 2025, with the product supplied from AmerisourceBergen's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.62 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 31, 2025. This award was made on a firm fixed price basis with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,049.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.38 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,417.62 and is scheduled for completion by August 22, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $18,599.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Ceftriaxone 2 GM-D5W bags, with performance to be completed by September 5, 2025. This non-set-aside contract is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a common antibiotic used across military and federal healthcare systems. This firm fixed-price delivery order, valued at $6,774.10, was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a $1,302.13 delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM vials, a third-generation cephalosporin antibiotic commonly used in military and federal healthcare settings. The contract, awarded on June 27, 2025, is a firm fixed-price delivery order with a completion date of June 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJN71Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,142.63 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation, indicating competitive award based on the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's Medical Supply Chain, delivering a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems globally. The company's extensive federal contract portfolio with DLA demonstrates its capacity to fulfill diverse medical commodity needs across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This delivery order for Ceftriaxone supports the DLA's mission to provide essential medical supplies to Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 8/21/25 |